Single B cell antibody technologies

New Biotechnology

Volumn 28, Issue 5, 2011, Pages 453-457

  Tiller, Thomas ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; B-LINEAGE CELLS; BASIC RESEARCH; ENCODING GENES; MONOCLONAL ANTIBODIES (MABS); TECHNOLOGICAL CONCEPT; THERAPEUTIC VALUES;

CLONING; GENES; MONOCLONAL ANTIBODIES;

CLONE CELLS;

B LYMPHOCYTE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

B LYMPHOCYTE; DRUG IDENTIFICATION; DRUG ISOLATION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC TECHNIQUES;

EID: 80052802543     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2011.03.014     Document Type: Review

References (78)

1. Marasco W.A., Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 2007, 25:1421-1434.
2. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
3. Carter P.J. Potent antibody therapeutics by design. Nat. Rev. Immunol. 2006, 6:343-357.
4. Hwang W.Y., Foote J. Immunogenicity of engineered antibodies. Methods 2005, 36:3-10.
5. Almagro J.C., Fransson J. Humanization of antibodies. Front. Biosci. 2008, 13:1619-1633.
6. Boulianne G.L., et al. Production of functional chimaeric mouse/human antibody. Nature 1984, 312:643-646.
7. Jones P.T., et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986, 321:522-525.
8. Morrison S.L., et al. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:6851-6855.
9. Bruggemann M., Neuberger M.S. Strategies for expressing human antibody repertoires in transgenic mice. Immunol. Today 1996, 17:391-397.
10. Green L.L., et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. 1994, 7:13-21.
11. Lonberg N. Human antibodies from transgenic animals. Nat. Biotechnol. 2005, 23:1117-1125.
12. Lonberg N., et al. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 1994, 368:856-859.
13. Dessain S.K., et al. High efficiency creation of human monoclonal antibody-producing hybridomas. J. Immunol. Methods 2004, 291:109-122.
14. Gustafsson B., Hinkula J. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems. Hum. Antibodies Hybridomas 1994, 5:98-104.
15. Li J., et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3557-3562.
16. Steinitz M., et al. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977, 269:420-422.
17. Winter G., Milstein C. Man-made antibodies. Nature 1991, 349:293-299.
18. Yu X., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536.
19. Simmons C.P., et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 2007, 4:e178.
20. Traggiai E., et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 2004, 10:871-875.
21. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 2005, 23:1105-1116.
22. Lowe D., Jermutus L. Combinatorial protein biochemistry for therapeutics and proteomics. Curr. Pharm. Biotechnol. 2004, 5:17-27.
23. Rajpal A., et al. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8466-8471.
24. Steidl S., et al. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Mol. Immunol. 2008, 46:135-144.
25. Babcook J.S., et al. A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:7843-7848.
26. Jiang X., et al. A novel strategy for generation of monoclonal antibodies from single B cells using rt-PCR technique and in vitro expression. Biotechnol. Prog. 2006, 22:979-988.
27. Kantor A.B., et al. Development of the antibody repertoire as revealed by single-cell PCR of FACS-sorted B-cell subsets. Ann. N. Y. Acad. Sci. 1995, 764:224-227.
28. Lagerkvist A.C., et al. Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning. Biotechniques 1995, 18:862-869.
29. Meijer P.J., et al. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J. Mol. Biol. 2006, 358:764-772.
30. Smith K., et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 2009, 4:372-384.
31. Tiller T., et al. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 2009, 350:183-193.
32. Tiller T., et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 2008, 329:112-124.
33. Jin A., et al. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat. Med. 2009, 15:1088-1092.
34. Love J.C., et al. A microengraving method for rapid selection of single cells producing antigen-specific antibodies. Nat. Biotechnol. 2006, 24:703-707.
35. Ogunniyi A.O., et al. Screening individual hybridomas by microengraving to discover monoclonal antibodies. Nat. Protoc. 2009, 4:767-782.
36. Tajiri K., et al. Cell-microarray analysis of antigen-specific B-cells: single cell analysis of antigen receptor expression and specificity. Cytometry A 2007, 71:961-967.
37. Tokimitsu Y., et al. Single lymphocyte analysis with a microwell array chip. Cytometry A 2007, 71:1003-1010.
38. Kuppers R., et al. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993, 12:4955-4967.
39. Obiakor H., et al. A comparison of hydraulic and laser capture microdissection methods for collection of single B cells, PCR, and sequencing of antibody VDJ. Anal. Biochem. 2002, 306:55-62.
40. Wardemann H., et al. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377.
41. Battye F.L., et al. Single cell sorting and cloning. J. Immunol. Methods 2000, 243:25-32.
42. Herzenberg L.A., et al. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin. Chem. 2002, 48:1819-1827.
43. Scheid J.F., et al. A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 2009, 343:65-67.
44. Tickle S., et al. High-throughput screening for high affinity antibodies. J. Assoc. Lab. Automation 2009, 14:303-307.
45. Scheid J.F., et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636-640.
46. Wrammert J., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
47. Kantor A.B., et al. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J. Immunol. 1997, 158:1175-1186.
48. Kantor A.B., et al. Construction of cDNA from single unstimulated mouse B lymphocytes: method and application to the study of expressed antibody repertoires in FACS-sorted murine B cell subsets. Handbook of Experimental Immunology 1998, Blackwell, pp. 13.1-13.6. L.A. Herzenberg, C. Blackwell, L.A. Herzenberg (Eds.).
49. Coronella J.A., et al. Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells. Nucleic Acids Res. 2000, 28:E85.
50. Marks J.D., et al. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur. J. Immunol. 1991, 21:985-991.
51. Wang X., Stollar B.D. Human immunoglobulin variable region gene analysis by single cell RT-PCR. J. Immunol. Methods 2000, 244:217-225.
52. Liao H.X., et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 2009, 158:171-179.
53. Embleton M.J., et al. In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells. Nucleic Acids Res. 1992, 20:3831-3837.
54. Ozawa T., Kishi H., Muraguchi A. Amplification and analysis of cDNA generated from a single cell by 5'-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells. Biotechniques 2006, 40:469-470. 472, 474.
55. de Wildt R.M., et al. Somatic insertions and deletions shape the human antibody repertoire. J. Mol. Biol. 1999, 294:701-710.
56. Wilson P.C., et al. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J. Exp. Med. 1998, 187:59-70.
57. Brezinschek H.P., et al. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 1995, 155:190-202.
58. Ehlich A., Kuppers R. Analysis of immunoglobulin gene rearrangements in single B cells. Curr. Opin. Immunol. 1995, 7:281-284.
59. Ghia P., et al. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J. Exp. Med. 1996, 184:2217-2229.
60. ten B.E., et al. The status of Ig loci rearrangements in single cells from different stages of B cell development. Int. Immunol. 1995, 7:1013-1019.
61. Seidl K.J., et al. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int. Immunol. 1997, 9:689-702.
62. de Wildt R.M., et al. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J. Mol. Biol. 1999, 285:895-901.
63. Wardemann H., Nussenzweig M.C. B-cell self-tolerance in humans. Adv. Immunol. 2007, 95:83-110.
64. Isnardi I., et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008, 29:746-757.
65. Yurasov S., et al. B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 2005, 1062:165-174.
66. Yurasov S., et al. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 2006, 203:2255-2261.
67. Samuels J., et al. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 2005, 201:1659-1667.
68. Tsuiji M., et al. A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 2006, 203:393-400.
69. Koelsch K., et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 2007, 117:1558-1565.
70. Tiller T., et al. Autoreactivity in human IgG+ memory B cells. Immunity 2007, 26:205-213.
71. Manz R.A., et al. Maintenance of serum antibody levels. Annu. Rev. Immunol. 2005, 23:367-386.
72. Wu X., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010.
73. Poulsen T.R., et al. Kinetic, affinity, and diversity limits of human polyclonal antibody responses against tetanus toxoid. J. Immunol. 2007, 179:3841-3850.
74. Dohmen S.E., et al. Production of recombinant Ig molecules from antigen-selected single B cells and restricted usage of Ig-gene segments by anti-D antibodies. J. Immunol. Methods 2005, 298:9-20.
75. Tajiri K., et al. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antiviral Res. 2010.
76. Mietzner B., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9727-9732.
77. Casadevall A., Scharff M.D. Return to the past: the case for antibody-based therapies in infectious diseases. Clin. Infect. Dis. 1995, 21:150-161.
78. Newcombe C., Newcombe A.R. Antibody production: polyclonal-derived biotherapeutics. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 848:2-7.